跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
侯 甚光
副教授
,
急診學科
主治醫師
,
臺北醫學大學附設醫院
https://orcid.org/0000-0002-7011-9088
電子郵件
992001
h.tmu.edu
tw
h-index
630
引文
15
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2004
2025
每年研究成果
概覽
指紋
網路
專案
(1)
研究成果
(48)
類似的個人檔案
(6)
指紋
查看啟用 Sen-Kuang Hou 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Meta-Analysis
100%
Monocyte
96%
Emergency Department
91%
Neutrophil
62%
Lymphocyte
59%
COVID-19
56%
Sepsis
56%
Computer Assisted Tomography
49%
Apoplexy
45%
Odds Ratio
41%
Intensive Care Unit
39%
Foreign Body
37%
Randomized Clinical Trial
37%
Network Meta-Analysis
37%
Randomized Controlled Trial
34%
Scoring System
32%
Biological Marker
31%
Percutaneous Thrombectomy
31%
Symptom
30%
Ingestion
29%
Laparotomy
28%
Serositis
28%
Weakness
27%
Diagnostic Accuracy
25%
Computed Tomography Angiography
24%
Sensitivity and Specificity
24%
Esophagus
21%
Thorax Radiography
21%
Systematic Review
20%
Cell Count
20%
Leukocyte
20%
Brain Ischemia
20%
Gastrointestinal Bleeding
18%
Hemoperitoneum
18%
Gabexate Mesilate
18%
Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
18%
Carbon Monoxide Intoxication
18%
Spleen Rupture
18%
Systematic Review with Meta-Analysis
18%
Hyperbaric Medicine
18%
Medicine
18%
Tachypnea
18%
Digital Subtraction Angiography
18%
Thromboembolism
18%
Acute Kidney Injury
18%
Ectrodactyly
18%
Tranexamic Acid
18%
Community-Acquired Pneumonia
18%
Upper Respiratory Tract Infection
18%
Appendicitis
18%
Nursing and Health Professions
Meta Analysis
43%
Network Meta-Analysis
37%
Confidence Interval
31%
Emergency Ward
28%
Odds Ratio
25%
Neutrophil Lymphocyte Ratio
22%
Systematic Review
20%
Intensive Care Unit
20%
Inflammation
20%
Length of Stay
20%
Pilot Study
18%
Systematic Review with Meta-Analysis
18%
Heart Arrest
18%
Ward
18%
Gastrointestinal Hemorrhage
18%
Resuscitation
18%
Hepatitis B
18%
Carbon Monoxide Intoxication
18%
Blood Pressure Monitor
18%
Hyperbaric Medicine
18%
Morphine
18%
Acute Coronary Syndrome
18%
Disease
18%
Tranexamic Acid
18%
Sepsis
18%
Atrial Fibrillation
18%
Upper Respiratory Tract Infection
18%
Endoscopic Retrograde Cholangiopancreatography
18%
Pancreatitis
18%
Gabexate Mesilate
18%
Acute Cholecystitis
18%
Weakness
18%
Hospitalization
16%
Electrocardiogram
13%
Respiratory Tract Infection
11%
Predictive Value
10%
Diagnosis
8%
Neuromuscular Electrical Stimulation
8%
Bleeding
8%
Blood Pressure
8%
Logistic Regression Analysis
7%
Area under the Curve
7%
Clinical Outcome
7%
Oxygen Tension
6%
University Hospital
6%
Multiple Linear Regression Analysis
6%
Time Series Analysis
6%
Major Adverse Cardiac Event
6%
Practice Guideline
6%
Computer Assisted Tomography
6%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
49%
Randomized Clinical Trial
37%
Acute Kidney Failure
37%
Disease
26%
Acute Coronary Syndrome
22%
Biological Marker
20%
Infection
20%
Prospective Study
20%
Brain Ischemia
20%
Thromboembolism
18%
Hepatitis B Virus
18%
Clinical Trial
18%
Hepatitis B
18%
Gastrointestinal Hemorrhage
18%
Coronavirinae
18%
Carbon Monoxide Poisoning
18%
Gabexate Mesilate
18%
Mesenteric Ischemia
18%
Pancreatitis
18%
Ibuprofen
18%
Monotherapy
18%
Morphine
18%
Paracetamol
18%
Atrial Fibrillation
18%
Tranexamic Acid
18%
Hepcidin
18%
Sepsis
18%
Hypothyroidism
18%
Transient Ischemic Attack
18%
Inflammation
15%
Ferritin
12%
C Reactive Protein
11%
Acute Lung Injury
10%
Antiplatelet
10%
Bleeding
9%
Divalent
9%
CD71 Antigen
9%
Ferroportin
9%
Interleukin 6
8%
Adverse Event
8%
Pericardial Effusion
8%
Cytokine
7%
Random Effects Model
6%
Major Adverse Cardiac Event
6%
Memory Disorder
6%
Acute Heart Infarction
6%
Creatine Kinase
6%
Organ Dysfunction Score
6%
Observational Study
5%
Mouse
5%
